|
|
|
Insider
Information: |
Coughlin Christopher J |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
342,599 |
|
Indirect Shares
|
17,342 |
|
|
Direct
Value |
$12,307,323 |
|
|
Indirect Value
|
$3,201,457 |
|
|
Total
Shares |
359,941 |
|
|
Total
Value |
$15,508,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-5.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
Centene Corp |
CNC |
Director |
2024-05-14 |
25,504 |
2022-02-07 |
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PLXP |
Plx Pharma Inc |
Director |
|
2014-03-18 |
4 |
B |
$12.00 |
$24,996 |
D/D |
2,083 |
109,309 |
2.39 |
- |
|
COV |
Covidien Plc |
Director |
|
2014-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,264 |
50,062 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2014-03-19 |
4 |
D |
$70.68 |
$73,931 |
D/D |
(1,046) |
49,016 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,141 |
13,780 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2014-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
49,446 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-06-13 |
4 |
A |
$103.94 |
$5,891 |
D/D |
57 |
13,836 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2014-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,640 |
1,640 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2014-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
768 |
768 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-09-12 |
4 |
A |
$117.05 |
$5,892 |
D/D |
50 |
13,887 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2014-10-30 |
4 |
A |
$243.21 |
$168,788 |
D/D |
694 |
18,261 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2014-12-12 |
4 |
A |
$114.86 |
$5,914 |
D/D |
51 |
13,938 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2015-01-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,970) |
0 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2015-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(49,475) |
0 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-03-11 |
4 |
A |
$127.21 |
$6,241 |
D/D |
49 |
13,987 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
1,468 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
954 |
14,941 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2015-06-04 |
4 |
D |
$303.38 |
$101,329 |
D/D |
(334) |
2,000 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2015-06-05 |
4 |
A |
$302.30 |
$249,700 |
D/D |
826 |
2,826 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-06-12 |
4 |
A |
$129.73 |
$6,705 |
D/D |
52 |
14,993 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2015-08-15 |
4 |
D |
$314.50 |
$31,450 |
D/D |
(100) |
2,726 |
0 |
- |
|
AGN |
Allergan plc |
Director |
|
2015-08-23 |
4 |
D |
$298.57 |
$37,023 |
D/D |
(124) |
2,602 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-09-11 |
4 |
A |
$104.56 |
$6,729 |
D/D |
64 |
15,057 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-11-06 |
4 |
OE |
$71.28 |
$166,071 |
D/D |
2,330 |
17,387 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-11-06 |
4 |
S |
$112.50 |
$262,134 |
D/D |
(2,330) |
15,057 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2015-12-11 |
4 |
A |
$103.68 |
$6,758 |
D/D |
65 |
15,122 |
0 |
- |
|
180 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|